AIM2 and type 2 diabetes mellitus: Mitochondrial DNA from patients with type 2 diabetes mellitus can trigger AIM2 inflammasome-dependent caspase-1 activation, leading to the release of proinflammatory cytokines and promoting polarization to the M1 phenotype [121].